There is research on this stock available only to PRO subscribers.
We currently have no Breaking News on this stock.
IPXL vs. ETF Alternatives
Impax Laboratories, Inc., is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development.
Other News & PR